131 results
Page 3 of 7
424B3
tj81u57 l3ah
1 Jun 22
Prospectus supplement
4:06pm
8-K
EX-10.1
v63vm t9ozpxhx4
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
8-K
EX-10.2
8al46gnd9or8
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
424B3
89orha65wuk2ytqc
16 May 22
Prospectus supplement
8:20pm
424B3
6jdrjtgm80x7 9zmg
3 May 22
Prospectus supplement
4:06pm
POS AM
z07fxpfhuzu5ck8x6d
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
8-K
EX-10.1
8nifxvq
1 Mar 22
Entry into a Material Definitive Agreement
4:47pm
424B3
zsw09hfdd14
28 Dec 21
Prospectus supplement
4:05pm
8-K
EX-99.1
pnr6 7wha
28 Dec 21
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
4:01pm
424B3
kfoaalko02nt2m 11ni3
12 Nov 21
Prospectus supplement
4:45pm